August 2014 | The Journal of Targeted Therapies in Cancer

October 06, 2014

Hepatocellular cancer (HCC) is a rapidly fatal malignancy that is often diagnosed at an advanced stage when it is not curable. Despite a rise in incidence, this cancer is not as common in the Western world as it is in Asia and Africa.

September 22, 2014

Therapies targeted to tumor biology hold the promise of improved outcomes for patients with breast cancer.

September 20, 2014

The 5-year survival rate for patients with metastatic colorectal cancer (CRC) remains dismal. Liver metastases are a particularly common occurrence, developing in approximately half of all patients with colorectal cancer.